Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% dis ...

New research shows fat buildup disables brain’s immune defenses in Alzheimer’s. A mouse treatment cleared plaques in just one week.

New tool helps surgeons tell apart aggressive glioblastoma from other cancers in the brain, guiding real-time treatment ...

A natural psychoactive compound shows promise in protecting brain blood vessels and reducing inflammation, offering potential ...

AI and optogenetics pave the way for precision diagnosis and treatment in Parkinson’s disease, marking a major breakthrough ...